Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.
Open Access
- 1 September 1996
- Vol. 76 (3) , 243-249
- https://doi.org/10.1136/hrt.76.3.243
Abstract
OBJECTIVE: To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy. DESIGN: Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease. SETTING: University virology department and transplantation unit. METHODS: Reverse transcriptase-polymerase chain reaction and nucleotide sequence analysis of myocardial RNA and DNA; enterovirus-specific in situ hybridization; enterovirus-specific immunoglobulin M detection. RESULTS: Enterovirus RNA was detected in myocardial tissue from only a small proportion of (five of 75) hearts. However, although enterovirus-specific immunoglobulin M responses were detected in 22 (28%) of 39 controls patients, a significantly higher prevalence was observed among patients with dilated cardiomyopathy (22 (56%) of 39 patients; P < 0.005). All enteroviruses detected in myocardium showed greatest nucleotide sequence homology with coxsackievirus type B3. Detection of enterovirus RNA in myocardium by the polymerase chain reaction and by in situ hybridisation gave comparable results. Other potentially cardiotropic virus genomes, including human cytomegalovirus, influenzaviruses, and coronaviruses were not detected in myocardium. CONCLUSION: This study found that enterovirus-specific immunoglobulin M responses provided the strongest evidence of enterovirus involvement in patients with end-stage dilated cardiomyopathy. However, the high background prevalence of these responses limits their diagnostic value. The finding that enteroviruses detected in myocardium were coxsackievirus type B3 accords with recent findings in patients with acute myocarditis, and indicates that this serotype is the major cardiotropic human enterovirus.Keywords
This publication has 35 references indexed in Scilit:
- Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis.Heart, 1995
- Myocardial enterovirus infection with left ventricular dysfunction: A benign disease compared with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1995
- Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reactionAmerican Heart Journal, 1993
- Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathyJournal of Medical Virology, 1993
- An Experimental Model for Dilated Cardiomyopathy after Rabbit Coronavirus InfectionThe Journal of Infectious Diseases, 1992
- Use of the Polymerase Chain Reaction to Analyse Sequence Variation Within a Major Neutralizing Epitope of Glycoprotein B (gp58) in Clinical Isolates of Human CytomegalovirusJournal of General Virology, 1991
- Coxsackie B virus and postviral fatigue syndrome.BMJ, 1991
- CHRONIC RELAPSING PERICARDITIS AND DILATED CARDIOMYOPATHY: SEROLOGICAL EVIDENCE OF PERSISTENT ENTEROVIRUS INFECTIONThe Lancet, 1989
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980
- Antibodies to Coxsackie B viruses in congestive cardiomyopathy.Heart, 1979